Member Info for Merchantbanker

Recruiting at both sites. Why recruit in Littleport if Elisa tests not looking promising too.....

Just like Sainsbury’s don’t rns every single item the sell, ODX won’t rns every order. I am backing them to put a trading update out that will exceed expectations at some stage.

Certain that we are about to take a huge step forward. Capacity needs to be extended and I believe shortly we will start to see what they have been working towards over the last few months, which will continue to push the company forward.

Worth noting, and something we should aim to clear up in the Q&A, that the current capacity is based on 9-5 5 days a week. So capacity should be able to be expanded by double shifts and weekends. Recruitment and training is also a limiting factor in bringing capacity up to scale.

If you could go from 1m to 10m overnight it might be a good idea. But it has taken 3 months to go from 200k to 500k. There will be an extended lead time to get the machines as everyone wants them at the moment. If they can get that government order they could order new kit today and by the time it's ready have the cash to pay for it. There is also £3m for the two new tests which i very much doubt they have spent which they could use.

Just trying to think, why would lockdowns spike demand for antibody testing? Unless a positive test meant you were exempt from lockdown?

Also BBI solutions and Abingdon health tweeted the white paper at pretty much exactly the same time.

"Lockdowns will see spike in demand for COVID-19 antibody testing. From a finger prick to results in just 20 minutes, the AbC-19 antibody test provides frequent and reliable rapid testing."

Tricky - something interesting there you are referring to...... the age of the Self Test lateral flow is yet to begin and therefore the age of mass testing is yet to begin. This is where our main opportunities are. We are not behind the curve we are right on the edge of it. The age of the lab test is maturing and will decline once the self tests start to become widely available. Our products are last generation products, they wont be superseded like those of the early adopters.

Indeed... why another presentation.... they have absolutely zero obligation and could pick and choose the timing of this to suit them. Just so happens to be around the time we expect news on UK RTC. And launch of Mologic Antibody tests. And completion of scale up. If news was 2 weeks away, why not hold the presentation for 2 weeks?

They are not begging on Vox. If you want the share price to go up, you need new buyers coming in. To attract new buyers you need to give them a reason to buy. Like news and a presentation.

I also think the fact that it is hosted by Turner Pope and Vox rather than on the Investor Meet platform is significant too. It's clearly not an under the radar presentation, one they want wider expose of.

Defies logic.....

Company need to tell us whats going o......

Company announce investor presentation

FFS why are the company doing a presentation, i must sell immediately...

Admittedly they don't make it an easy ride for us.

Look at August 2019:

8th Aug - Investor Briefing announced for 19th Aug
16th Aug - Trading update
19th Aug - Presentation
20th Aug - News

21 Nov - Investor presentation announced for 4th Dec
25th Nov - News
2 Dec - News
4 Dec - Presentation

So it seems CK likes to go into presentations loaded with news, so it kind of blows the theory of no news before presentation. Sorry if you panic sold.

Cash - Rubbish code Business is already cash flow neutral/positive. You can see exactly what the funds are raised for in the prospectus

Because the UK Government want to control the timing of the release of these devices into the public domain. There needs to be a government policy in place for self tests and there needs to be enough supply available when this is announced

I’m certain we will see something before 5th. UK RTC MOU expires next week. Very much doubt they will do an investor presentation before an update on this.

They also say they are evaluating several other tests. And so far only firming up 10m of 500m tests expected over the next 12 months.

https://www.who.int/news-room/detail/28-09-2020-global-partnership-to-make-available-120-million-affordable-quality-covid-19-rapid-tests-for-low--and-middle-income-countries

Note 4 out of the 9 members of ACT are backers of Mologic.

https://www.who.int/initiatives/act-accelerator?sf-auth=Qq

" So where does ODX come in to play on this "
Well ODX have access to Mologic's tests to make and brand as their own. Therefore if Mologic have the test developed, appraised and approved, then we have the same.

Not a grant for development, but for manufacturing. Seeing as they already have a facility for the antibody tests you would have to assume this is for Antigen tests. Big green light that Mologic have cracked it. Mologic cracked it = Omega cracked it.

https://www.gatesfoundation.org/How-We-Work/Quick-Links/Grants-Database/Grants/2020/08/INV-022794

Bit silly to grant Mologic $27m

Anyone who doesn't know a lot about Mologic, see below..... this is what you should be excited about.

Backed by Gates Foundation, UK Government, Welcome Trust and Foundation for Innovative New Diagnostics

In 2015, the Gates Foundation approached Mologic to create the Centre for Advanced Rapid Diagnostics (CARD). CARD was set up with a $5m grant

Recently awarded $27m by the Gates foundation. The single largest health grant for Covid.

Covid-19 - A dual rapid test to detect viral antigens in saliva and IgM and IgG antibodies in a fingerprick of blood. The device will be made available rapidly at scale in a self test format to mitigate the effects of the current pandemic.

https://mologic.co.uk/our-core-markets/global-health/

Anyone that has never seen this article it's worth a read from April. It mentions Mologic antigen and antibody. 1 out of 2 in the bag.

https://www.360dx.com/infectious-disease/immunoassays-coronavirus-testing-including-self-tests-targeted-mologic#.X2NQzmhKiUk

Most people really do not appreciate what a big deal it is to have access to Mologic's tests. These are really at the cutting edge of the industry. Mologic have one of the founders of the clear blue pregnancy test, the first test of it's kind.

Colin has selected to work with Mologic's tests for a reason. They have proven expertise and proven success. 80% of our capacity reserved for these tests for a reason.

The lateral flow antigen device has been used in heathrow trials. The antibody device is a triple antibody test. These guys are not out there with methods that have only been tested in the lab trying to create value in their stock price, they are only interested in delivering solutions to tackle health problems.

Mologic test is worth £2.50 a test to ODX on 50% margin of £5 selling price. What do you think manufacturing another company's test is worth to ODX? - a lot less. Today's Fincapp note for that company puts the chance of success at 70% which is likely overstated rather than under.

Today has shown so many misconceptions that investors currently have. Our Mologic agreement is one of the most undervalued bits of business out there. They are material tech transfers giving us access to brand their developed products as Omega's. Omega are not just a manufacturer they are adding products to their portfolio to brand under the Visitect name. High margin products. The current planned manufacturing capacity is miniscule compared to the potential of the products already in the portfolio. I am backing Mologic to come forward with some announcements on Antigen tests very soon.

Lifesgoody - may i suggest the filter button if i'm irritating you.

We are talking about something mentioned in the Yorkshire Post.... with all due respect, I hardly think they are at the forefront of understanding relationships between the diagnostics business and are in receipt of and willing to disclose inside information.

The point i am making is why are you getting excited about the potential for something that is nowhere near as beneficial to us as what we already have?